MetLife, Inc. (NYSE: MET) is a Financial Services company in the Insurance - Life industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | S&P 500 | P/E | 18.37 | EPS (ttm) | 5.21 | Insider Own | 0.43% | Shs Outstand | 643.44M | Perf Week | 1.35% |
| Market Cap | 61.57B | Forward P/E | 8.61 | EPS next Y | 11.12 | Insider Trans | 0.00% | Shs Float | 537.49M | Perf Month | -1.38% |
| Enterprise Value | 60.42B | PEG | 1.76 | EPS next Q | 2.55 | Inst Own | 70.02% | Short Float | 2.10% | Perf Quarter | 11.83% |
| Income | 3.63B | P/S | 0.78 | EPS this Y | 92.46% | Inst Trans | 0.00% | Short Ratio | 2.98 | Perf Half Y | 35.54% |
| Sales | 78.65B | P/B | 2.21 | EPS next Y | 10.89% | ROA | 0.48% | Short Interest | 11.31M | Perf YTD | 21.22% |
| Book/sh | 43.21 | P/C | 0.18 | EPS next 5Y | 10.42% | ROE | 12.95% | 52W High | 100.93 -5.19% | Perf Year | 20.21% |
| Cash/sh | 526.54 | P/FCF | 3.79 | EPS past 3/5Y | -8.67% -3.31% | ROIC | 0.49% | 52W Low | 67.33 42.12% | Perf 3Y | 48.82% |
| Dividend Est. | 2.37 (2.48%) | EV/EBITDA | 10.14 | Sales past 3/5Y | 4.29% 2.57% | Gross Margin | 25.55% | Volatility | 1.91% 1.63% | Perf 5Y | 54.34% |
| Dividend TTM | 2.32 (2.42%) | EV/Sales | 0.77 | EPS Y/Y TTM | -12.29% | Oper. Margin | 6.19% | ATR (14) | 1.87 | Perf 10Y | 153.22% |
| Dividend Ex-Date | Aug 04, 2026 | Quick Ratio | 453.01 | Sales Y/Y TTM | 12.45% | Profit Margin | 4.61% | RSI (14) | 49.77 | Recom | 2.24 |
| Dividend Gr. 3/5Y | 4.31% 4.31% | Current Ratio | 453.01 | EPS Q/Q | 20.30% | SMA20 | -0.51% | Beta | 0.77 | Target Price | 101.00 |
| Payout | 46.36% | Debt/Eq | 0.70 | Sales Q/Q | 9.90% | SMA50 | 1.02% | Rel Volume | 0.89 | Prev Close | 95.50 |
| Employees | 46,000 | LT Debt/Eq | 0.64 | Earnings | Nov 04 | SMA200 | 16.47% | Avg Volume | 3.63M | Price | 95.69 |
| IPO Date | Apr 05, 2000 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 5.87% -3.00% | Net Debt/EBITDA | -0.40 | Volume | 3,220,206 | Change | 0.20% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-24-26 | Reiterated | Morgan Stanley | Overweight | $103 → $111 |
| Aug-19-26 | Reiterated | Wells Fargo | Overweight | $95 → $109 |
| Aug-06-26 | Reiterated | Barclays | Overweight | $94 → $97 |
| Jul-15-26 | Reiterated | Atlantic Equities | Overweight | $106 → $103 |
| Jul-10-26 | Reiterated | Jefferies | Buy | $82 → $103 |
| Jul-08-26 | Reiterated | UBS | Buy | $102 → $105 |
| Jul-07-26 | Reiterated | Barclays | Overweight | $93 → $94 |
| Jul-06-26 | Reiterated | Morgan Stanley | Overweight | $93 → $103 |
| Jun-24-26 | Reiterated | Piper Sandler | Neutral | $86 → $90 |
| May-26-26 | Reiterated | Piper Sandler | Neutral | $84 → $86 |
MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa (EMEA), and MetLife Holdings. Its broad insurance offerings include life, dental, group short-term and long-term disability, individual disability, pet, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans. MetLife also supports employers with administrative services-only (ASO) arrangements. Furthermore, it provides sophisticated financial instruments such as general and separate account contracts, synthetic guaranteed interest contracts, and private floating rate funding agreements. The company facilitates pension risk transfers, offers institutional income annuities, structures settlements, and delivers capital markets investment products. Specialized life insurance products and funding agreements are also available for post-retirement benefits, alongside company, bank, or trust-owned life insurance used to finance non-qualified executive benefit programs. In addition, MetLife offers a variety of annuity options including fixed, indexed-linked, and variable, alongside pension and regular savings products. Its life insurance portfolio features whole life, term life, endowments, universal and variable life, and group life policies. The company also provides longevity reinsurance solutions, credit insurance products, and protection for long-term healthcare services. MetLife, Inc. was founded in 1863 and is headquartered in New York City.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 78,646 | 77,084 | 69,939 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 58,550 | 49,060 | 50,940 | — | — | — | — | — | — | |
| Gross Profit | 20,096 | 28,024 | 18,999 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 3,216 | 0 | 5,991 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 12,012 | 23,363 | 7,386 | — | — | — | — | — | — | |
| Operating Income | 4,868 | 4,661 | 5,622 | — | — | — | — | — | — | |
| Interest Expense | 1,091 | 1,061 | 1,037 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 1,092 | 1,061 | 1,037 | — | — | — | — | — | — | |
| Net Income Before Taxes | 4,869 | 4,661 | 5,622 | — | — | — | — | — | — | |
| Income Taxes | 1,210 | 1,258 | 1,178 | — | — | — | — | — | — | |
| Consolidated Net Income | 3,626 | 3,379 | 4,426 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 3,659 | 3,403 | 4,444 | — | — | — | — | — | — | |
| Net Income | 3,626 | 3,379 | 4,426 | — | — | — | — | — | — | |
| EPS (Recurring) | 5.25 | 4.80 | 5.98 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 5.25 | 4.80 | 5.98 | — | — | — | — | — | — | |
| EPS (Diluted) | 5.21 | 4.80 | 5.94 | — | — | — | — | — | — | |
| EBITDA | 5,960 | 6,475 | 7,373 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 18.37 | 16.45 | 13.78 | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.79 | 0.68 | 0.81 | — | — | — | — | — | — | |
| Gross Margin | 25.55 | 36.36 | 27.17 | — | — | — | — | — | — | |
| Operating Margin | 6.19 | 6.05 | 8.04 | — | — | — | — | — | — | |
| Net Margin | 4.61 | 4.38 | 6.33 | — | — | — | — | — | — | |
| Shares Outstanding | 652 | 665 | 689 | — | — | — | — | — | — | |
| Market Capitalization | 62,390 | 52,495 | 56,415 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| PAPPAS BILL | EVP, Global Tech. & Ops. | May 12 '25 | Sale | 80.49 | 26,000 | 2,092,683 | 66,744 | May 13 |
| DEBEL MARLENE | EVP & Chief Risk Officer | Dec 13 '24 | Option Exercise | 39.26 | 22,810 | 895,428 | 131,317 | Dec 17 |
| DEBEL MARLENE | EVP & Chief Risk Officer | Dec 13 '24 | Sale | 82.88 | 22,810 | 1,890,577 | 108,507 | Dec 17 |
| Khalaf Michel | President & CEO | Dec 13 '24 | Option Exercise | 45.91 | 26,138 | 1,199,996 | 521,725 | Dec 17 |
| Khalaf Michel | President & CEO | Dec 13 '24 | Sale | 82.84 | 20,926 | 1,733,604 | 500,799 | Dec 17 |
| PAPPAS BILL | EVP, Global Tech. & Ops. | Mar 18 '24 | Sale | 72.27 | 27,000 | 1,951,325 | 57,768 | Mar 20 |
| TADROS RAMY | President, U.S. Business | Mar 13 '24 | Sale | 71.90 | 4,026 | 289,479 | 146,981 | Mar 14 |